- Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
- Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
- Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
Key statistics
As of last trade Longboard Pharmaceuticals Inc (LBPH:NMQ) traded at 20.58, -26.91% below its 52-week high of 28.15, set on Jan 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.83 |
---|---|
High | 20.72 |
Low | 18.68 |
Bid | 20.52 |
Offer | 20.62 |
Previous close | 18.67 |
Average volume | 466.85k |
---|---|
Shares outstanding | 36.03m |
Free float | 33.23m |
P/E (TTM) | -- |
Market cap | 672.65m USD |
EPS (TTM) | -2.39 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 19:12 BST.
More ▼